Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

2.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Cancer Prevention02:59

Cancer Prevention

8.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K
The Ras Gene02:38

The Ras Gene

7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
Tumor Progression02:07

Tumor Progression

7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Steady-state temperature field of multilayer overlying strata under an equivalent fixed-wall-temperature heat source: similarity experiments and 3D simulation.

Scientific reports·2026
Same author

Fluorescence detection strategy based on DNA tetrahedron and ATP-assisted signal amplification for intracellular hypochlorous acid imaging.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

Promoter methylation of MdRNS3a contributes to Alternaria leaf spot resistance in apple (Malus × domestica).

The New phytologist·2026
Same author

PDIA6 promotes the cell proliferation of ESCC by enhancing the disulfide bond formation in TRAF4.

Cellular & molecular biology letters·2026
Same author

Theoretical and experimental study of thermo electrical coupling mechanisms in coal bearing rocks.

Scientific reports·2025
Same author

Research on the dust transportation law and cyclone air curtain dust control technology of coalface.

Scientific reports·2025

Related Experiment Video

Updated: Feb 28, 2026

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

47.9K

[Molecular basis for prostate carcinogenesis].

Fangzhi Chen1, Xiaokun Zhao1

  • 1Department of Urology, Second Xiangya Hospital, Central South University, Changsha 410011, China.

Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences
|June 20, 2017
PubMed
Summary
This summary is machine-generated.

Prostate cancer, a common male cancer, often becomes castration-resistant despite initial treatment. Molecular oncology studies reveal key genes and variations influencing cancer development, improving future prevention and diagnosis.

More Related Videos

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

9.2K
Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on: November 22, 2019

9.6K

Related Experiment Videos

Last Updated: Feb 28, 2026

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

47.9K
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

9.2K
Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on: November 22, 2019

9.6K

Area of Science:

  • Urology
  • Oncology
  • Molecular Biology

Background:

  • Prostate cancer is the most common male urogenital malignancy.
  • Androgen deprivation therapy is the primary treatment, but castration-resistant prostate carcinoma frequently develops.
  • Molecular oncology has identified numerous genes and variations linked to prostate cancer.

Purpose of the Study:

  • To summarize the molecular basis of prostate cancer development.
  • To highlight the role of genetic factors in prostate carcinogenesis.
  • To underscore the implications of molecular findings for clinical practice.

Main Methods:

  • Review of molecular oncology studies.
  • Analysis of genetic variations in prostate cancer.
  • Synthesis of findings on oncogenes and tumor suppressor genes.

Main Results:

  • Identification of multiple susceptibility genes, tumor suppressor genes, and oncogenes.
  • Understanding the variations relevant to prostate cancer occurrence and progression.
  • Elucidation of the molecular mechanisms underlying prostate carcinogenesis.

Conclusions:

  • Molecular insights are crucial for understanding prostate cancer.
  • Knowledge of genetic factors can enhance prevention and diagnosis strategies.
  • Further research into molecular oncology will improve clinical management of prostate carcinoma.